OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise
Amit Kumar Singh, Shiv Vardan Singh, Ramesh Kumar, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 1, pp. 1-18
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
Aviral Kumar, Bandari BharathwajChetty, Mukesh Kumar Manickasamy, et al.
Pharmacological Research (2024) Vol. 203, pp. 107167-107167
Open Access | Times Cited: 6

Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.
H. B. Singh, Hitesh Chopra, Inderbir Singh, et al.
PubMed (2024) Vol. 23, pp. 300-334
Closed Access | Times Cited: 6

lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer
Asif Ahmad Bhat, Muhammad Afzal, Ehssan Moglad, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Anti-tumor Effects of Polyphenols via Targeting Cancer Driving Signaling Pathways: A Review
Kareena Moar, Somu Yadav, Anuja Pant, et al.
Indian Journal of Clinical Biochemistry (2024) Vol. 39, Iss. 4, pp. 470-488
Closed Access | Times Cited: 5

Selenium-copper hyaluronic acid nanoparticles: A novel green synthesis for improved anticancer activity against HepG2 liver cancer cells
Mohammad Fazel Vafadar, Yasin Ghabool, Kimia Ahmadi, et al.
Inorganic Chemistry Communications (2025) Vol. 173, pp. 113869-113869
Closed Access

Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies
Sunil Kumar Sah, Sama Ajay, Asawari Dilip Donadkar, et al.
International Journal of Pharmaceutics (2025), pp. 125261-125261
Closed Access

Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma
Guanjie Ji, Yue Li, Zhiyue Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24667-e24667
Open Access | Times Cited: 4

Research progress on natural products against hepatocellular carcinoma
LINGLI ZHANG, Yan Li, Jingxin Mao
Biocell (2024) Vol. 48, Iss. 6, pp. 905-922
Open Access | Times Cited: 3

m6A modification of VEGFA mRNA by RBM15/YTHDF2/IGF2BP3 contributes to angiogenesis of hepatocellular carcinoma
Xiaoxin Xu, Shu-Xiang Wu, Yi Zhang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 11, pp. 2174-2189
Closed Access | Times Cited: 3

Green synthesis and characterization of silicate nanostructures coated with Pluronic F127/gelatin for triggered drug delivery in tumor microenvironments
Ndumiso Vukile Mdlovu, Ruey‐Shin Juang, Meng‐Tzu Weng, et al.
International Journal of Biological Macromolecules (2023) Vol. 251, pp. 126337-126337
Closed Access | Times Cited: 9

Mechanism and recent updates on insulin-related disorders
Shashank Kumar, Sabyasachi Senapati, Neetu Bhattacharya, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 25, pp. 5840-5856
Open Access | Times Cited: 9

Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization
Qichao Hu, Wenwen Zhang, Feng Wei, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 1, pp. 280-304
Closed Access | Times Cited: 8

Comparative bioactivity analysis of hydro-methanolic extracts of root, leaf, and inflorescence of Tupistra nutans Wall. ex Lindl: An in vitro study on antioxidant and anti-hepatocellular carcinoma activity
A.C. Roy, Abhinav Prasad, Shivangi Singh, et al.
Biocatalysis and Agricultural Biotechnology (2023) Vol. 52, pp. 102819-102819
Closed Access | Times Cited: 7

Protective role of hesperetin in sorafenib-induced hepato- and neurotoxicity in mice via modulating apoptotic pathways and mitochondrial reprogramming
Dalia Zaafar, Heba M. A. Khalil, Reham El‐Naggar, et al.
Life Sciences (2023) Vol. 336, pp. 122295-122295
Closed Access | Times Cited: 6

Protein profiles reveal MSH6/MSH2 as a potential biomarker for hepatocellular carcinoma with microvascular invasion
Shengqian Hong, Jialing Zhang, Shiqi Liu, et al.
Hepatology Research (2023) Vol. 54, Iss. 2, pp. 189-200
Open Access | Times Cited: 5

Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers
M Djaldetti
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 9, pp. 1389-1399
Open Access | Times Cited: 1

Advancements in Utilizing Natural Compounds for Modulating Autophagy in Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Md. Ataur Rahman, S M Rakib-Uz-Zaman, Somdeepa Chakraborti, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1186-1186
Open Access | Times Cited: 1

Synergistic enhancement: Exploring the potential of piperine in cancer therapeutics through chemosensitization and combination therapies
Mukesh Kumar Manickasamy, Aviral Kumar, Bandari BharathwajChetty, et al.
Life Sciences (2024) Vol. 354, pp. 122943-122943
Closed Access | Times Cited: 1

Hyperkouytones A—O, New Polyprenylated Acylphloroglucinols from Hypericum kouytchense with Multidrug Resistance Reversal Activity
Huayong Lou, Meijun Chen, Ping Yi, et al.
Chinese Journal of Chemistry (2024)
Closed Access | Times Cited: 1

Baicalein Targets MAPK9 to Induce Apoptosis of Hepatocellular Carcinoma Cells
Weili Wang, Yuxiao Tang, Xiaobin Zhuo, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 3
Closed Access | Times Cited: 1

Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment
Sumit Roy, Vancha Harish, Sharfuddin Mohd, et al.
Advanced Therapeutics (2024)
Closed Access

Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications
Mona M. AbouSamra
Journal of Liposome Research (2024) Vol. 34, Iss. 4, pp. 728-743
Closed Access

Computational Screening of FDA‐Approved Hepatitis C Drugs for Inhibition of VEGFR2 in Liver Cancer
Miah Roney, Abdul Rashid Issahaku, Nasir Tufail, et al.
ChemistrySelect (2024) Vol. 9, Iss. 35
Closed Access

Mitochondrial cholesterol metabolism related gene model predicts prognosis and treatment response in hepatocellular carcinoma
Xin Guo, Feng Wang, Xuejing Li, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 12, pp. 6623-6644
Open Access

Page 1 - Next Page

Scroll to top